SBC Medical Group (SBC) Fair Value & Analysis
Industrials · US · Market cap $303M
SBC Medical Group
SBC · US
Fair value as of: Jun 25, 2026
From 22 valuation models · updated 4 days ago
Share price −1.9% over the past month.
Price vs Fair Value (12 months)
12‑month range $2.80 – $5.51 · fair‑value band $5.45 – $9.09 · the $3.07 price screens below the $7.20 fair value. As of Jun 25, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
SBC Medical Group (SBC) currently trades at $3.07, while our model-based Fair Value estimate is $7.20 — implying the stock looks roughly 134.5% undervalued today. We read business quality at 85/100 (high quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, SBC Medical Group generated revenue of $169M at a net margin of 24.1%. Revenue declined 9.0% year over year. It earns a return on equity of 16.5%. The balance sheet holds a net cash position of $112M. Fundamentals as of Jun 25, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 25, 2026. TTM = trailing twelve months.
About the company
SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals; leasehold improvement services; and design services for clinics, medical equipment, and medical consumables procurement. It also provides loyalty program management, labor and function supporting, and management consulting services; and IT software solutions, as well as engages in franchising activities; and distributes medical equipment and devices, implants, injection materials, other medical consumables, skin care and beauty products, and cosmetic products to franchisee clinics for resale to clinic customers. In addition, the company offers surgical a…
Revenue & earnings trend
FY2022 – FY2025 · reported fiscal years
SBC Medical Group reported revenue of $174M in FY2025 versus $174M in FY2022, a compound −0.1%/yr. Reported net income was $51.0M in FY2025, compounding +100.6%/yr from FY2022.
Open the full interactive analysis →
Similar stocks
6 more Consulting Services stocks, each showing price versus our Fair Value estimate (as of Jun 25, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Experian plc EXPGY | $32.96 | $29.60 | -10% |
| SGS SA SGSOF | $110.42 | $84.42 | -24% |
| Verisk Analytics, Inc VRSK | $181.73 | $89.91 | -51% |
| Equifax Inc EFX | $153.49 | $101.37 | -34% |
| Bureau Veritas SA BVRDF | $30.75 | $25.47 | -17% |
| Booz Allen Hamilton Holding BAH | $63.88 | $120.81 | +89% |
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is SBC Medical Group (SBC) undervalued?
What is the fair value of SBC?
What is the quality score of SBC?
What is the revenue of SBC Medical Group (SBC)?
What is the net profit margin of SBC?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.